We are live on
!
Find out more
Temasek Holdings Portfolio holdings
AUM
$30.5B
1-Year Est. Return
13.98%
This Fund
S&P 500
This Quarter
Est. Return
+0.22%
1 Year Est. Return
+13.98%
3 Year Est. Return
+73.05%
5 Year Est. Return
+59.18%
10 Year Est. Return
+409.11%
AUM
$17.2B
AUM Growth
-$1.83B
(-9.6%)
Cap. Flow
-$1.5B
Cap. Flow
% of AUM
-8.7%
Top 10 Holdings %
Top 10 Hldgs %
69.28%
Holding
65
New
3
Increased
3
Reduced
10
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$127M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$42.9M |
| 3 |
BP
BP
|
+$26.1M |
| 4 |
AC Immune
ACIU
|
+$12.8M |
| 5 |
COUP
Coupa Software Incorporated
COUP
|
+$929K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.15B |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$110M |
| 3 |
Illumina
ILMN
|
+$73.1M |
| 4 |
JD.com
JD
|
+$65.1M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.18% |
| 2 | Communication Services | 20.05% |
| 3 | Healthcare | 14.09% |
| 4 | Financials | 11.93% |
| 5 | Materials | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cognex
CGNX
$10B
| $7.77M | 0.05% |
139,192
| – | – |
|
|
COUP
52
DELISTED
Coupa Software Incorporated
COUP
| $4M | 0.02% |
50,597
+13,380
| +36% | +$929K |
|
|
AYX
53
DELISTED
Alteryx Inc
AYX
| $626K | ﹤0.01% |
+10,939
| New | +$557K |
|
54
Okta
OKTA
$23.7B
| $496K | ﹤0.01% |
7,046
| – | – |
|
55
Amgen
AMGN
$211B
| – | – |
-188,527
| Closed | -$34.8M |
|
56
Biogen
BIIB
$30.2B
| – | – |
-118,644
| Closed | -$34.4M |
|
57
Walt Disney
DIS
$172B
| – | – |
-70,600
| Closed | -$7.4M |
|
58
Incyte
INCY
$26.2B
| – | – |
-252,160
| Closed | -$16.9M |
|
59
Medtronic
MDT
$111B
| – | – |
-107,300
| Closed | -$9.19M |
|
|
60
Vertex Pharmaceuticals
VRTX
$124B
| – | – |
-244,582
| Closed | -$41.6M |
|
61
State Street SPDR S&P Transportation ETF
XTN
$401M
| – | – |
-388,458
| Closed | -$24.5M |
|
|
AMRS
62
DELISTED
Amyris Inc.
AMRS
| – | – |
-363,155
| Closed | -$2.32M |
|
|
NETS
63
DELISTED
Netshoes (Cayman) Limited
NETS
| – | – |
-127,501
| Closed | -$302K |
|
|
CELG
64
DELISTED
Celgene Corp
CELG
| – | – |
-255,406
| Closed | -$20.3M |
|
Similar funds
Temasek Holdings's Q3 2018 Portfolio in Review
As of Q3 2018, Temasek Holdings held 65 positions worth $17.2B, down 9.6% from $19B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Temasek Holdings withdrew a net $1.5B in Q3 2018, closing 10 positions and reducing 10 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $41.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, down from 40% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Temasek Holdings opened a new position in Farfetch Limited Class A Ordinary Shares worth $122M.
- Temasek Holdings's largest Q3 2018 buy was Farfetch Limited Class A Ordinary Shares: 4,470,415 shares worth $122M.
- Temasek Holdings added most to Royal Dutch Shell PLC ADS Class B in Q3 2018, an estimated $42.9M increase.
- Temasek Holdings's biggest Q3 2018 reduction was Alibaba, cutting an estimated $1.15B.
- Temasek Holdings fully exited Vertex Pharmaceuticals in Q3 2018, selling an estimated $41.6M.
- Temasek Holdings's ten largest holdings make up 69% of its $17.2B portfolio in Q3 2018.
- Temasek Holdings opened 3 new positions and closed 10 in Q3 2018.
- Temasek Holdings's portfolio value fell 9.6% quarter-over-quarter to $17.2B.
Based on Temasek Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.